WHO Pharmaceuticals Newsletter 1997, No. 11&12
(1997; 24 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentAlendronic acid - oesophagitis: Australia
View the documentBenzodiazepines in pregnancy and lactation - reminder: to be avoided: United Kingdom
View the documentDrug-induced gynaecomastia - review of reports: Australia
View the documentGinkgo biloba - spontaneous haemorrhage: New Zealand
View the documentHydroxyamfetamine/tropicamide (ParemydR) - adverse reactions: United States of America
View the documentMethotrexate (low-dose) - blood dyscrasias and other adverse reactions: United Kingdom
View the documentPethidine - convulsions: Australia
View the documentPyrithyldione/diphenhydramine - agranulocytosis: Spain
View the documentTherapeutic switches - evaluation of risks: call for data: United States of America
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Open this folder and view contentsVeterinary medicine

Pyrithyldione/diphenhydramine - agranulocytosis: Spain

Spain. The Pharmacovigilance Centre of the Institut Catala de Farmacologia has received three more reports of agranulocytosis associated with the combination hypnotic sedative, pyrithyldione/diphenhydramine (So”odorR), since it drew attention to this reaction in July 1996. The Centre reiterates its strong recommendation to withdraw this product from the market, especially in view of the lack of information on pyrithildione and the fact that, although So”odorR is a prescription medicine, it is often dispensed without prescription.

[See also Pharmaceuticals Newsletter No. 9, September 1996].

Reference: Butlleti Groc 10(3): 12 (1997), Institut Catala de Farmacologia, Universitat Autonoma de Barcelona.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018